TARDBP and amyotrophic lateral sclerosis: For example, in TDP-43 it is well-established that acetylation can act as a strong modulator of ALS pathogenicity, affecting both TDP-43 aggregation propensity and cytoplasmic mislocalization (Cohen et al., 2015; Sanna et al., 2020).